Gender-based difference in quality of life of Migraine sufferers: A Cross-Sectional Study
Abstract
Objective: To assess gender-based differences in quality of life among individuals with migraines.
Methods: This is a cross-sectional study, that took place at the Ibn-e-Seena Hospital and Fazaia Ruth Pfau Medical College and its affiliated teaching hospital of Karachi, from Aug 2023 to Jan 2024, in which a total of 200 patients enrolled who met the ICHD-3 proposed migraine criteria through convenient sampling. Every individual was administered the MIDAS (Migraine Disability Assessment Questionnaire) questionnaire to estimate the effects of migraines on their routine activity SPSS 22 version was used for data feeding and analysis. The results of qualitative/categorical variables were given in numbers and percentages and for quantitative variables in Mean ± S.D. A statistically significant. p- value was considered as <0.05
Results: 200 participants who were enrolled in this study were with an average age of 22.7±8.62 years with 65.5% being female. Among the participants, the majority (40.5%) fell into the 15-24 years of age, followed by 32% in the 25-34 years of age group. Among the participants, a MIDAS Grade score of 0–5, was achieved by 4 males and two females, indicating minimal to no disability. A MIDAS Grade score of 6–10 was achieved by 16 males and 34 females, indicating mild disability. Out of those with a MIDAS Grade score of 11–20, 29 and 51 were male and female respectively, signifying a moderate level of disability. A score of 21 or higher in MIDAS Grade, was…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause. Reported size: 200 participants or records.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.